Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
US7709610 | NA | Therapeutic use of anti-CS1 antibodies |
Mar, 2029
(5 years from now) |
Ingredients: ELOTUZUMAB
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic